Mogelijk is onderstaande een mooie kans voor Onward om samen te werken m.b.t. Arc im en deep brain stimulation.
Congratulations to our co-founders and research partners, G. Courtine and Jocelyne Bloch of .NeuroRestore, for their recent Nature Medicine publication on deep brain stimulation and its potential to help people with paralysis, which has been highlighted by media outlets like the The Economist. We look forward to learning more about this exciting new frontier! ??
#EmpoweringMovement #SCI #DBS
Note: All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
Profiel weergeven voor Dave Marver, afbeelding
Dave Marver 3e+
Chief Executive Officer at ONWARD Medical (Euronext: ONWD)
6 d
It's nice to see G. Courtine and Jocelyne Bloch recognized in The Economist for their recent publication in Nature Medicine. They found that stimulation in an unexpected location of the deep brain can help people with paralysis recover some walking function. This is interesting for ONWARD Medical because it could lead to a future therapy that combines our ARC-IM Therapy (spinal cord stimulation) with deep-brain stimulation (DBS) to achieve more effective outcomes. Early but promising research coming out of .NeuroRestore, as always.